Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP498662.RA0oXBVlUMx4br10Q63S_ueuIrM4DB26kHJu5C4hhM_mA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP498662.RA0oXBVlUMx4br10Q63S_ueuIrM4DB26kHJu5C4hhM_mA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP498662.RA0oXBVlUMx4br10Q63S_ueuIrM4DB26kHJu5C4hhM_mA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP498662.RA0oXBVlUMx4br10Q63S_ueuIrM4DB26kHJu5C4hhM_mA130_provenance.
- NP498662.RA0oXBVlUMx4br10Q63S_ueuIrM4DB26kHJu5C4hhM_mA130_assertion description "[The role of interaction of polymorphisms in the Renin-Angiotensin-System (RAS) with angiotensin converting enzyme (ACE) or angiotensin receptor (AGTR1) inhibitors (RAS inhibitors) is unknown, as is the role of such therapy in end stage renal disease (ESRD) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP498662.RA0oXBVlUMx4br10Q63S_ueuIrM4DB26kHJu5C4hhM_mA130_provenance.
- NP498662.RA0oXBVlUMx4br10Q63S_ueuIrM4DB26kHJu5C4hhM_mA130_assertion evidence source_evidence_literature NP498662.RA0oXBVlUMx4br10Q63S_ueuIrM4DB26kHJu5C4hhM_mA130_provenance.
- NP498662.RA0oXBVlUMx4br10Q63S_ueuIrM4DB26kHJu5C4hhM_mA130_assertion SIO_000772 15946912 NP498662.RA0oXBVlUMx4br10Q63S_ueuIrM4DB26kHJu5C4hhM_mA130_provenance.
- NP498662.RA0oXBVlUMx4br10Q63S_ueuIrM4DB26kHJu5C4hhM_mA130_assertion wasDerivedFrom befree-2016 NP498662.RA0oXBVlUMx4br10Q63S_ueuIrM4DB26kHJu5C4hhM_mA130_provenance.
- NP498662.RA0oXBVlUMx4br10Q63S_ueuIrM4DB26kHJu5C4hhM_mA130_assertion wasGeneratedBy ECO_0000203 NP498662.RA0oXBVlUMx4br10Q63S_ueuIrM4DB26kHJu5C4hhM_mA130_provenance.
- befree-2016 importedOn "2016-02-19" NP498662.RA0oXBVlUMx4br10Q63S_ueuIrM4DB26kHJu5C4hhM_mA130_provenance.